Delta-aminolevulinic Acid Cytotoxic Effects on Human Hepatocarcinoma Cell Lines

Overview

Journal BMC Cancer

Publisher Biomed Central

Specialty Oncology

Date 2002 Mar 27

PMID 11914144

Citations 6

Authors

Adriana De Siervi

Elba S Vazquez

Carolina Rezaval

Maria V Rossetti

Alcira M del Batlle

Affiliations

Soon will be listed here.

Abstract

Background: Acute Intermittent Porphyria is a genetic disorder of heme metabolism, characterized by increased levels of porphyrin precursors, delta-aminolevulinic acid (ALA) and porphobilinogen (PBG). ALA has been reported to generate reactive oxygen species and to cause oxidative damage to proteins, subcellular structures and DNA. It is known that oxidative stress can induce apoptosis. The aim of this work was to study the cytotoxic effect of ALA on two hepatocarcinoma cell lines.

Results: We have determined the impact of ALA on HEP G2 and HEP 3B hepatocarcinoma cell lines survival as measured by the MTT assay. ALA proved to be cytotoxic in both cell lines however; HEP G2 was more sensitive to ALA than HEP 3B. Addition of hemin or glucose diminished ALA cytotoxicity in HEP G2 cells; instead it was enhanced in HEP 3B cells. Because apoptosis is usually associated with DNA fragmentation, the DNA of ALA treated and untreated cells were analyzed. The characteristic pattern of DNA fragmentation ladders was observed in ALA treated cells. To elucidate the mechanisms of ALA induced apoptosis, we examined its effect on p53 expression. No changes in p53 mRNA levels were observed after exposure of both cell lines to ALA for 24 h. CDK2 and CDK4 protein levels were reduced after ALA treatment at physiological concentrations.

Citing Articles

Liver transplantation and primary liver cancer in porphyria.

Lissing M, Wang B, Wahlin S Liver Int. 2024; 45(3):e15894.

PMID: 38456621 PMC: 11815609. DOI: 10.1111/liv.15894.

RNA interference therapy in acute hepatic porphyrias.

Yasuda M, Keel S, Balwani M Blood. 2023; 142(19):1589-1599.

PMID: 37027823 PMC: 10656724. DOI: 10.1182/blood.2022018662.

Risk of primary liver cancer in acute hepatic porphyria patients: A matched cohort study of 1244 individuals.

Lissing M, Vassiliou D, Floderus Y, Harper P, Bottai M, Kotopouli M J Intern Med. 2022; 291(6):824-836.

PMID: 35112415 PMC: 9311710. DOI: 10.1111/joim.13463.

In vitro toxicological assessment of gadolinium (III) chloride in V79-4 fibroblasts.

Siew E, Farris A, Rashid N, Chan K, Rajab N Genes Environ. 2020; 42:22.

PMID: 32537035 PMC: 7288472. DOI: 10.1186/s41021-020-00161-3.

Combination of 5-aminolevulinic acid and ferrous ion reduces plasma glucose and hemoglobin A1c levels in Zucker diabetic fatty rats.

Hara T, Koda A, Nozawa N, Ota U, Kondo H, Nakagawa H FEBS Open Bio. 2016; 6(6):515-28.

PMID: 27239432 PMC: 4880722. DOI: 10.1002/2211-5463.12048.

References

Raff M, Barres B, Burne J, Coles H, Ishizaki Y, Jacobson M . Programmed cell death and the control of cell survival. Philos Trans R Soc Lond B Biol Sci. 1994; 345(1313):265-8. DOI: 10.1098/rstb.1994.0104. View

Meijer L . Chemical inhibitors of cyclin-dependent kinases. Trends Cell Biol. 1996; 6(10):393-7. DOI: 10.1016/0962-8924(96)10034-9. View

Lowe S, Bodis S, McClatchey A, Remington L, Ruley H, Fisher D . p53 status and the efficacy of cancer therapy in vivo. Science. 1994; 266(5186):807-10. DOI: 10.1126/science.7973635. View

Garrett M, Fattaey A . CDK inhibition and cancer therapy. Curr Opin Genet Dev. 1999; 9(1):104-11. DOI: 10.1016/s0959-437x(99)80015-x. View

Hardell L, Bengtsson N, Jonsson U, Eriksson S, Larsson L . Aetiological aspects on primary liver cancer with special regard to alcohol, organic solvents and acute intermittent porphyria--an epidemiological investigation. Br J Cancer. 1984; 50(3):389-97. PMC: 1976799. DOI: 10.1038/bjc.1984.188. View

Darlington G, Kelly J, Buffone G . Growth and hepatospecific gene expression of human hepatoma cells in a defined medium. In Vitro Cell Dev Biol. 1987; 23(5):349-54. DOI: 10.1007/BF02620991. View

Knowles B, HOWE C, Aden D . Human hepatocellular carcinoma cell lines secrete the major plasma proteins and hepatitis B surface antigen. Science. 1980; 209(4455):497-9. DOI: 10.1126/science.6248960. View

Stein J, TSCHUDY D . Acute intermittent porphyria. A clinical and biochemical study of 46 patients. Medicine (Baltimore). 1970; 49(1):1-16. View

Russell V, Lamm M, Taljaard J . Effects of delta-aminolaevulinic acid, porphobilinogen and structurally related amino acids on 2-deoxy-glucose uptake in cultured neurons. Neurochem Res. 1982; 7(8):1009-22. DOI: 10.1007/BF00965140. View

10.

Bonkowsky H, TSCHUDY D, Collins A, Doherty J, Bossenmaier I, Cardinal R . Repression of the overproduction of porphyrin precursors in acute intermittent porphyria by intravenous infusions of hematin. Proc Natl Acad Sci U S A. 1971; 68(11):2725-9. PMC: 389510. DOI: 10.1073/pnas.68.11.2725. View

11.

Nath K . Heme oxygenase-1: a redoubtable response that limits reperfusion injury in the transplanted adipose liver. J Clin Invest. 1999; 104(11):1485-6. PMC: 409870. DOI: 10.1172/JCI8827. View

12.

Onuki J, Medeiros M, Bechara E, Di Mascio P . 5-Aminolevulinic acid induces single-strand breaks in plasmid pBR322 DNA in the presence of Fe2+ ions. Biochim Biophys Acta. 1994; 1225(3):259-63. DOI: 10.1016/0925-4439(94)90004-3. View

13.

Wagener F, Feldman E, de Witte T, Abraham N . Heme induces the expression of adhesion molecules ICAM-1, VCAM-1, and E selectin in vascular endothelial cells. Proc Soc Exp Biol Med. 1997; 216(3):456-63. DOI: 10.3181/00379727-216-44197. View

14.

Bressac B, Galvin K, Liang T, Isselbacher K, Wands J, Ozturk M . Abnormal structure and expression of p53 gene in human hepatocellular carcinoma. Proc Natl Acad Sci U S A. 1990; 87(5):1973-7. PMC: 53607. DOI: 10.1073/pnas.87.5.1973. View

15.

Lithner F, Wetterberg L . Hepatocellular carcinoma in patients with acute intermittent porphyria. Acta Med Scand. 1984; 215(3):271-4. DOI: 10.1111/j.0954-6820.1984.tb05005.x. View

16.

BATLLE A . Porphyrins, porphyrias, cancer and photodynamic therapy--a model for carcinogenesis. J Photochem Photobiol B. 1993; 20(1):5-22. DOI: 10.1016/1011-1344(93)80127-u. View

17.

Douki T, Onuki J, Medeiros M, Bechara E, Cadet J, Di Mascio P . DNA alkylation by 4,5-dioxovaleric acid, the final oxidation product of 5-aminolevulinic acid. Chem Res Toxicol. 1998; 11(2):150-7. DOI: 10.1021/tx970157d. View

18.

Kauppinen R, Mustajoki P . Acute hepatic porphyria and hepatocellular carcinoma. Br J Cancer. 1988; 57(1):117-20. PMC: 2246695. DOI: 10.1038/bjc.1988.23. View

19.

Aden D, FOGEL A, Plotkin S, Damjanov I, Knowles B . Controlled synthesis of HBsAg in a differentiated human liver carcinoma-derived cell line. Nature. 1979; 282(5739):615-6. DOI: 10.1038/282615a0. View

20.

Wider de Xifra E, BATLLE A, Stella A, MALAMUD S . Acute intermittent porphyria--another approach to therapy. Int J Biochem. 1980; 12(5-6):819-22. DOI: 10.1016/0020-711x(80)90169-x. View